In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinsons disease which can be attenuated by glycyrrhizin
(2) Mitochondrial evasion: Inhibition of intraneuronal MAO-A prevents tyramine degradation, allowing cytoplasmic accumulation
Batch: GF-BPCTB5-B241 BPC-157 Assay: 7.36 mg BPC-157 Purity: 99.2 percent BPC-157 Identification by RT: 0.995 Molecular Ion Mass Identification (BPC-157): 1418 Da TB-500 Assay: 6.11 mg TB-500 Purity: greater than 99.8 percent TB-500 Identification by RT: 0.996 Molecular Ion Mass Identification (TB-500): 4963 Da Bacterial Endotoxins: below 0.001 EU/mg Total Aerobic Microbial Count: Not detected Total Yeast and Mold Count: Not detected Research Applications In controlled laboratory environments, BPC-157 / TB-500 may be utilised in experimental models designed to investigate peptide signalling systems and molecular interaction pathways
Increases Collagen Production: It may improve collagen synthesis, which is essential for maintaining the structure of connective tissues, skin, and joints
Preclinical research has shown it may significantly increase the number of new synapses in the hippocampus and promote neurovascular protection and repair
PMID: 41625068 Last updated: March 25, 2026
